DNA repair after irradiation in glioma cells and normal human astrocytes.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 1994097)

Published in Neuro Oncol on August 17, 2007

Authors

Susan C Short1, Christine Martindale, Sara Bourne, Geoff Brand, Mick Woodcock, Peter Johnston

Author Affiliations

1: Department of Oncology, University College London, 250 Euston Rd., London NW1 2PG, UK. s.short@ucl.ac.uk

Articles citing this

Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS One (2010) 1.39

Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms. Proc Natl Acad Sci U S A (2009) 1.34

Localized CT-guided irradiation inhibits neurogenesis in specific regions of the adult mouse brain. Radiat Res (2011) 1.30

Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90. Mol Cancer Ther (2009) 1.20

Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. Neuro Oncol (2011) 1.02

Cytotoxic autophagy in cancer therapy. Int J Mol Sci (2014) 0.99

NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro Oncol (2011) 0.92

Nonhomologous DNA end joining in cell-free extracts. J Nucleic Acids (2010) 0.86

KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis. Biomed Res Int (2014) 0.82

In vitro effects of Cyberknife-driven intermittent irradiation on glioblastoma cell lines. Neurol Sci (2011) 0.79

LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential. Cancer Biol Ther (2015) 0.79

Functional interrogation of adult hypothalamic neurogenesis with focal radiological inhibition. J Vis Exp (2013) 0.78

Glioma-amplified sequence KUB3 influences double-strand break repair after ionizing radiation. Int J Oncol (2013) 0.76

Evidence for L1-associated DNA rearrangements and negligible L1 retrotransposition in glioblastoma multiforme. Mob DNA (2016) 0.75

DNA damage of glioblastoma multiform cells induced by Beta radiation of iodine-131 in the presence or absence of topotecan: a picogreen and colonogenic assay. Cell J (2015) 0.75

RECQ1 Helicase Silencing Decreases the Tumour Growth Rate of U87 Glioblastoma Cell Xenografts in Zebrafish Embryos. Genes (Basel) (2017) 0.75

Articles cited by this

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55

MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem (1998) 28.13

A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol (2000) 13.46

Genetic pathways to primary and secondary glioblastoma. Am J Pathol (2007) 9.27

Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol (2003) 8.55

A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature (2005) 4.33

Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (1995) 4.19

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature (2005) 3.90

Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J Cell Biol (2005) 2.64

Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res (1998) 2.63

Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol Gen Genet (1996) 2.00

Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res (2002) 2.00

Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res (1994) 1.86

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58

Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics. Int J Cancer (2006) 1.53

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res (2003) 1.53

Does gammaH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett (2005) 1.52

Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J Biol Chem (2004) 1.49

Underestimation of the small residual damage when measuring DNA double-strand breaks (DSB): is the repair of radiation-induced DSB complete? Int J Radiat Biol (1999) 1.43

Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. Toxicology (2003) 1.38

Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res (2005) 1.35

Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys (2000) 1.34

In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem Biophys Res Commun (1998) 1.34

In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs (1997) 1.32

p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res (2003) 1.32

Analysis of ionizing radiation-induced foci of DNA damage repair proteins. Mutat Res (2005) 1.17

Low dose hypersensitivity in the T98G human glioblastoma cell line. Int J Radiat Biol (1999) 1.12

P53 inhibits strand exchange and replication fork regression promoted by human Rad51. J Mol Biol (2004) 1.11

Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026. Br J Cancer (2005) 1.07

The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial. Clin Cancer Res (2005) 1.07

DNA damage responses at low radiation doses. Radiat Res (2005) 0.94

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction. J Neurosurg (1999) 0.88

p53 modulates radiation sensitivity independent of p21 transcriptional activation. Am J Clin Oncol (2005) 0.86

Induction and repair of radiation-induced DNA double-strand breaks in human fibroblasts are not affected by terminal differentiation. DNA Repair (Amst) (2004) 0.79

Articles by these authors

Tunable gold catalysts for selective hydrocarbon oxidation under mild conditions. Nature (2005) 2.61

Chk1 promotes replication fork progression by controlling replication initiation. Proc Natl Acad Sci U S A (2010) 1.71

European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy. J Clin Oncol (2010) 1.70

Kidney-derived stromal cells modulate dendritic and T cell responses. J Am Soc Nephrol (2009) 1.51

Exploring stakeholders' views of medical education research priorities: a national survey. Med Educ (2014) 1.48

PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys (2004) 1.06

Selective oxidation of glycerol to glyceric acid using a gold catalyst in aqueous sodium hydroxide. Chem Commun (Camb) (2002) 1.06

Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. Neuro Oncol (2011) 1.02

Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys (2009) 0.96

Enculturation to medicine: power for teachers or empowering learners? Med Educ (2012) 0.93

Australian diagnostic reference levels for multi detector computed tomography. Australas Phys Eng Sci Med (2013) 0.87

Jaw adductor muscles across lepidosaurs: a reappraisal. Anat Rec (Hoboken) (2011) 0.85

Hepatocellular carcinoma during pregnancy: case report and review of the literature. N Z Med J (2012) 0.85

Stress shield: a model of police resiliency. Int J Emerg Ment Health (2008) 0.83

Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. Radiother Oncol (2011) 0.81

A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601. ANZ J Surg (2007) 0.79

Spontaneous rupture of the oesophagus after bowel preparation with polyethylene glycol. ANZ J Surg (2004) 0.79

An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry. Radiother Oncol (2008) 0.78

A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study). Pediatr Diabetes (2013) 0.77

Long term OSLD reader stability in the ACDS level one audit. Australas Phys Eng Sci Med (2014) 0.75

The characterisation of supported platinum nanoparticles on carbon used for enantioselective hydrogenation: a combined electrochemical-STM approach. Chemphyschem (2003) 0.75

Outcomes after oesophagogastrectomy for carcinoma of the oesophagus. ANZ J Surg (2007) 0.75

Paediatric liver transplantation in New Zealand: the first 5 years. N Z Med J (2007) 0.75

Live donor liver transplantation in New Zealand: a report on the first 20 cases. N Z Med J (2009) 0.75

Blood glucose level prediction based on support vector regression using mobile platforms. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75